Skip to main content

Peer Review reports

From: Design and rationale for the WARFA trial: a randomized controlled cross-over trial testing the therapeutic equivalence of branded and generic warfarin in atrial fibrillation patients in Brazil

Original Submission
4 Apr 2017 Submitted Original manuscript
19 Apr 2017 Author responded Author comments - Carolina Gomes Freitas
Resubmission - Version 2
19 Apr 2017 Submitted Manuscript version 2
Publishing
1 Jun 2017 Editorially accepted
7 Jun 2017 Article published 10.1186/s12872-017-0584-4

You can find further information about peer review here.

Back to article page

BMC Cardiovascular Disorders

ISSN: 1471-2261

Contact us